Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free SXTPW Stock Alerts

60 Degrees Pharmaceuticals (SXTPW) Competitors

60 Degrees Pharmaceuticals logo
$0.05 0.00 (-0.43%)
As of 03:30 PM Eastern
Compare

SXTPW vs. DRTSW, APLMW, BIVIW, CDIOW, and CELUW

Should you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does 60 Degrees Pharmaceuticals compare to Alpha Tau Medical?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Alpha Tau Medical Neutral

Summary

60 Degrees Pharmaceuticals beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Apollomics?

Apollomics (NASDAQ:APLMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
60 Degrees Pharmaceuticals Neutral

Summary

Apollomics beats 60 Degrees Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to BioVie?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats BioVie on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Cardio Diagnostics?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
Cardio Diagnostics$14.83KN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Cardio Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Celularity?

Celularity (NASDAQ:CELUW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A

In the previous week, Celularity's average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Celularity Neutral
60 Degrees Pharmaceuticals Neutral

Summary

Celularity beats 60 Degrees Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXTPW vs. The Competition

Export
Metric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$446.03M$6.24B$11.86B
Dividend YieldN/A3.86%2.73%5.21%
P/E RatioN/A4.1929.0428.48
Price / SalesN/A6,879.71477.1060.43
Price / CashN/A13.1327.6236.52
Price / BookN/A77.749.676.67
Net IncomeN/A-$96.07M$3.55B$332.64M
7 Day PerformanceN/A0.71%1.70%2.01%
1 Month PerformanceN/A3.87%5.62%9.19%
1 Year PerformanceN/A48.54%34.42%39.59%

60 Degrees Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-0.4%		N/AN/A$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$1.05
-0.9%		N/AN/A$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-0.7%		N/AN/A$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.25
-13.1%		N/AN/A$0.00N/AN/AN/A
CDIOW
Cardio Diagnostics
N/A$0.02
+1.3%		N/AN/A$0.00$14.83KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SXTPW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel